Health knowledge made personal
Articles
(April 17, 2006)--Initial results of the Study of Tamoxifen and Raloxifene, or STAR, show that the drug raloxifene, currently used to prevent and treat osteoporosis in postmenopausal women, works...
called Study of Tamoxifen and Raloxifene (STAR) has been running to compare the effectiveness of raloxifene to tamoxifen for reducing breast cancer risk. The updated results from this trial were presented... 
-strengthening drug raloxifene, sold under the brand-name Evista, be approved to reduce the risk of breast cancer..., but it increases risk for uterine cancer and blood clots. Raloxifene, which also blocks estrogen production...
raloxifene shows clear advantage in preserving cognition
23 sept 2009-- The selective estrogen receptor modulators tamoxifen and raloxifene, used for breast cancer prevention in postmenopausal women...
looking at tamoxifen and raloxifene for breast cancer prevention. Many trumpeted the summary findings — “raloxifene is as effective, with fewer side effects!” — but with studies like these, the devil lies... 
found that raloxifene (marketed under the name of Evista) reduces their chance of developing breast cancer... use raloxifene to reduce the risk of osteoporosis, many will be more comfortable using it for breast cancer...
Medications Reduce Postmenopausal Fracture Risk
Teriparatide, raloxifene linked to reduced risk... with osteoporosis, teriparatide and raloxifene may significantly reduce the risk of vertebral fractures, according...
looking at tamoxifen and raloxifene for breast cancer prevention. Many trumpeted the summary findings — “raloxifene is as effective, with fewer side effects!” — but with studies like these, the devil lies... 
Trusted Partner Sites
Wellpedia